Veterinary Pharmacovigilance Market Report 2025

This Veterinary Pharmacovigilance market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The veterinary pharmacovigilance market size has grown rapidly in recent years. It will grow from $0.81 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to increasing awareness of animal health, growth in the companion animal population, rising demand for livestock products, expanding veterinary services, and higher prevalence of zoonotic diseases.

The veterinary pharmacovigilance market size is expected to see rapid growth in the next few years. It will grow to $1.5 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to increasing pet ownership and spending, rising veterinary expenditure, growing focus on animal welfare, expansion of telemedicine in veterinary services, and higher demand for personalized veterinary care. Major trends in the forecast period include adoption of digital reporting systems, expansion of telehealth services for veterinary care, integration of blockchain for data security, and development of cloud-based pharmacovigilance platforms.

The increasing demand for animal health and medicinal products is projected to drive the growth of the veterinary pharmacovigilance market. Animal health and medicine products include food, medications, and grooming items designed to support the health and well-being of pets. This growing demand is fueled by rising pet ownership, advances in veterinary medicine, and the need to boost livestock productivity. Moreover, greater awareness of animal welfare and a higher incidence of animal diseases are contributing to this surge. Veterinary pharmacovigilance plays a crucial role in pet care by ensuring the safety and effectiveness of medications through monitoring and assessing adverse effects and ensuring regulatory compliance. For example, the Republic of Estonia's Agency of Medicines (Ravimiamet) reported in March 2024 that the veterinary medicinal products sector grew by 6.9% in 2023, reaching 18.6 million euros, compared to 17.4 million euros in 2022. This growth in demand for animal health and medicinal products is expected to drive the veterinary pharmacovigilance market.

Key companies in the veterinary pharmacovigilance sector are concentrating on enhancing regulatory frameworks through developments in data analytics, such as adverse event reporting (REAS) and safety report preparation. These processes involve documenting and analyzing harmful reactions to veterinary drugs to assess safety and ensure compliance with regulatory standards. For instance, in August 2024, Mexico's Ministry of Agriculture and Rural Development launched a new veterinary pharmacovigilance system. Developed by SENASICA, this system aims to ensure the safety, quality, and efficacy of veterinary drugs in Mexico. It gathers data on adverse reactions from various stakeholders, including pharmaceutical companies, distributors, veterinary hospitals, and veterinarians, to identify, assess, and mitigate risks associated with these medications. The system includes the veterinary pharmacovigilance guide (REAS) for documenting adverse reactions and monitoring issues such as efficacy, residue limits, and environmental impacts.

In January 2024, Veterinary Pharmaceutical Solutions, a US-based company specializing in veterinary services, acquired Diamond Animal Health, Inc. for an undisclosed amount. This acquisition is intended to expand Veterinary Pharmaceutical Solutions' product range, enhance its research and development capabilities, and improve operational efficiencies within the animal health industry. Diamond Animal Health Inc. is a US-based contract manufacturing and research firm offering regulatory affairs consulting, a component of veterinary pharmacovigilance services.

Major companies operating in the veterinary pharmacovigilance market are Accenture PLC, Zoetis Inc, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Covetrus Inc, IDEXX Laboratories, Inc., Ceva Santé Animale, Virbac SA, Merck Animal Health, Huvepharma EOOD, Norbrook Laboratories Ltd, ProPharma Group, ArisGlobal LLC, PQE Group, Chanelle Pharma Group Ltd, Clinvet International, Ennov SAS, Sarjen Systems Pvt. Ltd, PharSafer Associates Ltd, Medfiles Oy, Azierta Contract Science Support Consulting, Knoell Germany GmbH, Triveritas Ltd, Leon Research, Biologit, Indivirtus Group.

North America was the largest region in the veterinary pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary pharmacovigilance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Veterinary pharmacovigilance is the field focused on detecting, assessing, understanding, and preventing adverse effects or other drug-related issues in animals. It involves monitoring and evaluating the safety and efficacy of veterinary medicines after their approval. The aim is to ensure that the benefits of these medicines outweigh the risks, thus promoting animal health and welfare while also protecting human health and the environment.

The main types of veterinary pharmacovigilance are in-house and outsourced. In-house pharmacovigilance involves the monitoring and assessment of adverse drug reactions and safety-related data conducted by the pharmaceutical or veterinary company itself. This includes the use of software and services for products such as biologics and anti-infectives. The scope covers various animal types, including companion animals, livestock, and others. End users of these services include veterinary hospitals, veterinary companies, and academic and research institutes.

The veterinary pharmacovigilance market research report is one of a series of new reports that provides veterinary pharmacovigilance market statistics, including veterinary pharmacovigilance industry global market size, regional shares, competitors with an veterinary pharmacovigilance market share, detailed veterinary pharmacovigilance market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary pharmacovigilance industry. This veterinary pharmacovigilance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary pharmacovigilance market consists of revenues earned by entities by providing services such as monitoring adverse drug reactions, assessing medication safety, collecting and analyzing safety data, conducting risk management, and ensuring regulatory compliance for veterinary medicines. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary pharmacovigilance market also includes sales of databases, reporting systems, safety assessment tools, and monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.